TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

A retrospective cohort study, conducted by researchers at the University of Freiburg, provides a comprehensive analysis of immune reconstitution and infection outcomes following allogeneic...

A recent study published in Journal for Immunotherapy of Cancer investigates the utility of DNA barcoded peptide-major histocompatibility complex (pMHC) multimers in detecting and monitoring minor...

Study findings support the oral microbiome as a potential pathway for preventing or managing chronic graft-versus-host disease (cGVHD) following hematopoietic cell transplantation (HCT).

Recent studies from Vall d’Hebron University Hospital, Heidelberg University Hospital, and the European Society for Blood and Marrow Transplantation (EBMT) provide valuable insights into the...

While both are accepted rescue therapies for classic Hodgkin lymphoma (cHL) relapse, research suggests immune checkpoint inhibitors (ICIs) offer an advantage over chemotherapy.

Researchers have learned that dimethyl fumarate (DMF), already known to suppress acute graft-versus-host disease (GVHD) without undermining graft-versus-leukemia effect, also has therapeutic...